OSR Health, Inc. (OSRHW)Bellevue, United States | NasdaqCM
0.03 USD
+0.03
(-11.348%)
⇧
(Aug. 25, 2026, 10:56 a.m.
EDT)
|
Hot Take ↕ | Oct. 10, 2026, 7:52 a.m. EDT
The investment case here is nonexistent due to a catastrophic collapse in both business fundamentals and market price. Revenue has plummeted by 72%, while the company burns cash aggressively with negative operating and free cash flows, resulting in severe losses on both assets and equity. The balance sheet is dangerously impaired, carrying nearly four times more debt than equity with a current ratio of just 0.18, signaling an imminent liquidity crisis. The stock price has effectively evaporated, trading at a fraction of book value and hitting a 52-week low of $0.01, where it has remained stagnant for over two weeks. With no analyst coverage, no dividend history, and a complete lack of statistical data to predict future moves, this security represents a total loss of capital rather than a distressed opportunity. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 4.373 |
| Revenue per Share | 0.064 |
| Beta | 0.48 |
| Previous Name | OSR Holdings, Inc. |
| Website | https://osr-holdings.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.6666666 |
| Address1 | 10,900 NE 4th Street |
| Address2 | Suite 2300 |
| All Time High | 0.03 |
| All Time Low | 0.01 |
| Ask | 0.061 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 0 |
| Average Daily Volume3 Month | 886 |
| Average Volume | 886 |
| Average Volume10Days | 0 |
| Beta | 0.482 |
| Bid | 0.0801 |
| Bid Size | 10 |
| Book Value | 2.969 |
| City | Bellevue |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.025 |
| Current Ratio | 0.182 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.0282 |
| Day Low | 0.025 |
| Debt To Equity | 4.373 |
| Ebitda | -7,419,085 |
| Ebitda Margins | 0.0 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 15 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 0.015862068 |
| Fifty Day Average Change | 0.009137932 |
| Fifty Day Average Change Percent | 0.57608706 |
| Fifty Two Week Change Percent | -66.666664 |
| Fifty Two Week High | 0.03 |
| Fifty Two Week High Change | -0.004999999 |
| Fifty Two Week High Change Percent | -0.16666664 |
| Fifty Two Week Low | 0.01 |
| Fifty Two Week Low Change | 0.015000001 |
| Fifty Two Week Low Change Percent | 1.5000001 |
| Fifty Two Week Range | 0.01 - 0.03 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,788,355,800,000 |
| Float Shares | 13,167,402 |
| Free Cashflow | -2,679,485 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 22 |
| Fullday Change | 0.025 |
| Fullday Change Percent | -11.347518 |
| Fullday Price | 0.025 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.33396998 |
| Gross Profits | 604,060 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Language | en-US |
| Long Business Summary | OSR Health, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Europe, and Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma completed phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. The company was formerly known as OSR Holdings, Inc. and changed its name to OSR Health, Inc. in June 2026. OSR Health, Inc. was incorporated in 2020 and is based in Bellevue, Washington. |
| Long Name | OSR Health, Inc. |
| Market | us_market |
| Market State | POST |
| Max Age | 86,400 |
| Message Board Id | finmb_1847710486 |
| Name Change Date | 2,026-10-14 |
| Net Income To Common | -10,729,865 |
| Open | 0.0417 |
| Operating Cashflow | -7,203,837 |
| Operating Margins | -9.6079 |
| Phone | 425 635 7700 |
| Prev Name | OSR Holdings, Inc. |
| Previous Close | 0.0 |
| Price Hint | 4 |
| Price To Book | 0.0084203435 |
| Profit Margins | 0.0 |
| Quick Ratio | 0.111 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.025 |
| Regular Market Change Percent | -11.347518 |
| Regular Market Day High | 0.0282 |
| Regular Market Day Low | 0.025 |
| Regular Market Day Range | 0.025 - 0.0282 |
| Regular Market Open | 0.0417 |
| Regular Market Previous Close | 0.0 |
| Regular Market Price | 0.025 |
| Regular Market Time | 1,787,669,811 |
| Regular Market Volume | 21,220 |
| Return On Assets | -0.059970003 |
| Return On Equity | -0.11294 |
| Revenue Growth | -0.722 |
| Revenue Per Share | 0.064 |
| Sand P52 Week Change | 0.17004645 |
| Sector | |
| Sector Key | |
| Source Interval | 15 |
| State | WA |
| Symbol | OSRHW |
| Total Cash | 1,499,603 |
| Total Cash Per Share | 0.043 |
| Total Debt | 5,462,785 |
| Total Revenue | 1,808,743 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | NaN |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 0.015862068 |
| Two Hundred Day Average Change | 0.009137932 |
| Two Hundred Day Average Change Percent | 0.57608706 |
| Type Disp | Equity |
| Volume | 21,220 |
| Website | https://osr-holdings.com |
| Zip | 98,004 |